Previous study showed that LECT2 expression is significantly elevated in nonalcoholic fatty liver disease, and LECT2 induces the development and progression of Nonalcoholic fatty liver disease through the STAT-1 signal pathway (Wang et al., 2021). Here, STAT1 is linked to metabolic dysfunction-associated steatotic liver disease.